United States

Health News


U.S. jury fails to reach verdict in latest J&J talc trial May 25 2018

NEW YORK A South Carolina jury on Friday could not agree on a verdict in a case of a woman whose family said her long-term use of Johnson & Johnson's Baby Powder led to her death from asbestos-related cancer, resulting in a mistrial.

More Headlines

VA health systems vary widely in heart disease death rates

(Reuters Health) - Heart disease death rates vary substantially at Veterans Affairs hospitals nationwide, and a new study suggests that this holds true not just for hospitalized patients but also for outpatients.

May 25 2018

J&J must pay $4 million in punitive damages in latest asbestos cancer trial

A California jury on Thursday ordered Johnson & Johnson to pay $4 million in punitive damages to a woman who said she developed cancer after being exposed to asbestos in the company's baby powder, pushing the total damages award in the case to $25.7 million.

May 24 2018

FDA approves BioMarin rare metabolic disorder drug, shares rise

U.S. regulators on Thursday approved BioMarin Pharmaceutical Inc's Palynziq for adults with phenylketonuria, a rare metabolic disorder, sending shares of the biotechnology company up 3 percent after hours.

May 24 2018

Pressured by industry, U.S. EPA slows formaldehyde study release: documents

WASHINGTON The U.S. Environmental Protection Agency, under pressure from the chemical industry, has delayed release of a study detailing cancer risks from formaldehyde, according to internal communications seen by Reuters, potentially keeping important health information from the public.

Environment May 24 2018